Yew Bio-Pharm Group, Inc. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/20fa6f52-d70c-4d7b-8e25-63a3c1f463c5/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $27.3M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-007242 |
| FY 2019 | $27.9M | 2019-01-01 – 2019-12-31 | evidence 0001493152-21-007242 |
| FY 2018 | $37.6M | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-007971 |
| FY 2017 | $40.5M | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-003854 |
| FY 2016 | $51.3M | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-003143 |
| FY 2015 | $29.6M | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-012043 |
| FY 2014 | $7.7M | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002328 |
| FY 2013 | $7.4M | 2013-01-01 – 2013-12-31 | evidence 0001213900-14-001859 |
| FY 2012 | $6.7M | 2012-01-01 – 2012-12-31 | evidence 0001213900-13-001732 |
| FY 2011 | $6.0M | 2011-01-01 – 2011-12-31 | evidence 0001213900-13-001732 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Yew Bio-Pharm Group, Inc. — all facts · Net Income · Operating Income